CAS: 319425-66-6 - Cf 1743
Formula:C22H26N2O5
InChI:InChI=1S/C22H26N2O5/c1-2-3-4-5-14-6-8-15(9-7-14)18-10-16-12-24(22(27)23-21(16)29-18)20-11-17(26)19(13-25)28-20/h6-10,12,17,19-20,25-26H,2-5,11,13H2,1H3/t17-,19+,20+/m0/s1
InChI key:InChIKey=MFGSDSRTGUVZQG-DFQSSKMNSA-N
SMILES:O=C1N=C2OC(=CC2=CN1C3OC(CO)C(O)C3)C=4C=CC(=CC4)CCCCC
- Synonyms:
- Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)-
- 3-(2-Deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
- Cf 1743
CF 1743-d7 (Major)
Controlled ProductCAS:319425-66-6
Applications CF 1743-d7 is labelled Cf 1743 (C291710) which is an orally available nucleoside analogue …
Formula:
C22D7H19N2O5
Color and Shape:
Neat
Molecular weight:
405.495
Ref: TR-C291712
1mg | 259.00 € | ||
10mg | 1,746.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
CF 1743
Controlled ProductCAS:319425-66-6
Applications CF 1743 is an orally available nucleoside analogue drug with antiviral activity. It is …
Formula:
C22H26N2O5
Color and Shape:
Neat
Molecular weight:
398.45
Ref: TR-C291710
25mg | 268.00 € | ||
250mg | 1,746.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
CF 1743-d7 (Major)
CAS:319425-66-6
CF 1743-d7 is a synthetic antiviral drug that was developed to treat herpes simplex virus, …
Formula:
C22H19D7N2O5
Purity:
Min. 95%
Molecular weight:
405.5 g/mol
Ref: 3D-UMA42566
25mg | 772.00 € | ||
50mg | 1,162.00 € | ||
100mg | 1,617.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
CF-1743
CAS:319425-66-6
CF-1743 is an anti-varicella zoster virus nucleoside and inhibits VZV replication.
Formula:
C22H26N2O5
Purity:
100% - 99.16%
Color and Shape:
Solid
Molecular weight:
398.45
Ref: TM-T26987
1mg | 49.00 € | ||
5mg | 96.00 € | ||
10mg | 142.00 € | ||
25mg | 202.00 € | ||
50mg | 282.00 € | ||
100mg | 400.00 € | ||
200mg | 552.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025